160 related articles for article (PubMed ID: 2893970)
1. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
Meneilly GS; Minaker KL; Elahi D; Rowe JW
Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin does not alter insulin-mediated glucose disposal.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin enhances insulin-mediated glucose disposal in elderly subjects.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1988 Aug; 67(2):407-10. PubMed ID: 2899090
[TBL] [Abstract][Full Text] [Related]
4. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.
Nair KS
J Clin Endocrinol Metab; 1987 May; 64(5):896-901. PubMed ID: 2881943
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog.
Stevenson RW; Steiner KE; Williams PE; Cherrington AD
Metabolism; 1987 May; 36(5):451-7. PubMed ID: 2883556
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
Schmitz O
Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
[TBL] [Abstract][Full Text] [Related]
7. Glucagon and glucose tolerance in liver cirrhosis.
Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
[TBL] [Abstract][Full Text] [Related]
8. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.
Larsson H; Holst JJ; Ahrén B
Acta Physiol Scand; 1997 Aug; 160(4):413-22. PubMed ID: 9338524
[TBL] [Abstract][Full Text] [Related]
10. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
11. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
[TBL] [Abstract][Full Text] [Related]
12. Glucagon and hepatic glucose production: modulation by low-dose bradykinin infusion.
Hartl WH; Miyoshi H; Elahi D; Wolfe RR
Metabolism; 1989 Sep; 38(9):878-82. PubMed ID: 2570343
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism underlying the influence of alanine infusion on glucose dynamics in the dog.
Saccà L; Trimarco B; Perez G; Rengo F
Diabetes; 1977 Apr; 26(4):262-70. PubMed ID: 300341
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective insulin or glucagon deficiency on glucose turnover.
Lickley HL; Ross GG; Vranic M
Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
[TBL] [Abstract][Full Text] [Related]
15. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
16. Restoration of stable metabolic conditions during islet suppression in dogs.
Bradley DC; Bergman RN
Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
[TBL] [Abstract][Full Text] [Related]
17. Altered ability of the liver to produce glucose following a period of glucagon deficiency.
Deri JJ; Williams PE; Steiner KE; Cherrington AD
Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181
[TBL] [Abstract][Full Text] [Related]
18. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
Ross G; Lickley L; Vranic M
Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
Miller JD; Ganguli S; Sperling MA
Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.
Stevenson RW; Steiner KE; Hendrick GK; Cherrington AD
Am J Physiol; 1987 Oct; 253(4 Pt 1):E435-42. PubMed ID: 2889363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
